Finance

Lists
512070:BOM
UPL Ltd
₹533,50
-1,29%
(-6,95) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 512070...
Open
₹540,45
High
₹543,45
Low
₹532,40
Mkt. cap
451,92 mjd
Avg. vol.
156,80 k
Volume
28,40 k
Dividend
1,12%
Quarterly dividend
₹1,50
Ex-dividend date
17 Jul. 2026
P/E ratio
21,51
52-wk high
₹812,00
52-wk low
₹476,50
EPS
₹24,81
Shares outstanding
0,00
No. of employees
12 k
Open
₹540,45
High
₹543,45
Low
₹532,40
Mkt. cap
451,92 mjd
Avg. vol.
156,80 k
Volume
28,40 k
Dividend
1,12%
Quarterly dividend
₹1,50
Ex-dividend date
17 Jul. 2026
P/E ratio
21,51
52-wk high
₹812,00
52-wk low
₹476,50
EPS
₹24,81
Shares outstanding
0,00
No. of employees
12 k
News stories
From web sources and news partners
Profile
UPL Limited, formerly United Phosphorus Limited, is an Indian multinational company that manufactures and markets agrochemicals, industrial chemicals, chemical intermediates, and specialty chemicals. Headquartered in Mumbai, the company is primarily engaged in the manufacture and marketing of conventional agrochemicals, seeds, and other agriculture-related products. It also manufactures fungicides, herbicides, insecticides, plant growth regulators, rodenticides, industrial and specialty chemicals, and nutrifeeds. United Phosphorus Limited was established on 29 May 1969. The company changed its name to UPL Limited in October 2013. On 20 July 2018, UPL signed a US$4.2 billion agreement with Platform Specialty Products Corporation to acquire control of Arysta LifeScience Inc. The acquisition was completed in February 2019, making UPL the fifth largest generic agrochemicals company in the world after Bayer, Corteva, Syngenta and BASF. Wikipedia
About UPL Ltd
CEOJaidev Rajnikant Shroff
Employees12,4 k
Founded1969
HeadquartersBandra West, Maharashtra, Indië
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
120,19 mjd
122,69 mjd
183,35 mjd
101,81 mjd
Cost of goods sold
57,53 mjd
58,46 mjd
105,17 mjd
43,15 mjd
Cost of revenue
57,53 mjd
58,46 mjd
105,17 mjd
43,15 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,66 mjd
13,79 mjd
24,76 mjd
15,27 mjd
Operating expense
48,32 mjd
48,17 mjd
50,77 mjd
51,98 mjd
Total operating expenses
105,85 mjd
106,63 mjd
155,94 mjd
95,13 mjd
Operating income
14,34 mjd
16,06 mjd
27,41 mjd
6,68 mjd
Other non operating income
2,50 mjd
920,00 m
-6,04 mjd
2,17 mjd
EBT including unusual items
7,84 mjd
6,71 mjd
18,92 mjd
-1,09 mjd
EBT excluding unusual items
6,42 mjd
7,27 mjd
18,81 mjd
-1,00 mjd
Income tax expense
1,72 mjd
1,81 mjd
5,98 mjd
-360,00 m
Effective tax rate
21,94%
26,97%
31,61%
33,03%
Other operating expenses
24,81 mjd
25,46 mjd
13,07 mjd
27,33 mjd
Net income
5,53 mjd
3,96 mjd
10,61 mjd
100,00 m
Net profit margin
4,60%
3,23%
5,79%
0,10%
Earnings per share
8,09
4,87
12,70
0,19
Interest and investment income
-
-
5,26 mjd
-
Interest expense
-7,53 mjd
-7,00 mjd
-6,64 mjd
-7,59 mjd
Net interest expenses
-7,53 mjd
-7,00 mjd
-1,38 mjd
-7,59 mjd
Depreciation and amortization charges
7,71 mjd
8,27 mjd
9,15 mjd
8,32 mjd
EBITDA
21,85 mjd
19,14 mjd
31,10 mjd
10,37 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme